Aquis Stock Exchange
Live Markets
Raising capital for new-economy growth companies by offering a fast, straightforward and cost-efficient pathway to IPO.
View full list of companies
| Instrument | Mid Price | % Change | 18m Trend |
|---|---|---|---|
Inteliqo Limited IQO | 15.75 GBX | -3.08% | |
Shepherd Neame Ltd SHEP | 785 GBX | -0.63% | |
Ace Liberty & Stone plc ALSP | 57.5 GBX | 0.00% | |
Adnams plc ADB | 5,450 GBX | 0.00% | |
All Things Considered Group Plc ATC | 82.5 GBX | 0.00% |
As of 29-09-2023 01:51:28 GMT+00:00
Empowering growth companies
Our market is for entrepreneurial companies seeking visibility and access to growth capital. Its regulatory framework is specifically designed to meet the needs of growth companies.
Increase investment
Aquis Stock Exchange advocates putting the public back in public markets by providing access for both institutional and retail investors.
Service led
Our ‘open door’ policy and supportive team means you get to know us from day one, ensuring we understand your objectives and your growth trajectory is on-track.
Frontier sectors
Just like our companies, we like to push the boundaries, and aren’t shy of emerging sectors and new technologies.
Recent joiners
Unigel
Unigel Group is a global leader and pioneer in the field of thixotropic gels for the fibre optic cable industry, and a leading supplier of laminated steel tapes to the fibre optic cable industry in the US. The Group has positioned itself as a leader in the global fibre optic cable components industry and is a leading and key supplier of fibre optic cable components to the rapidly growing global fibre optic cable market.
View more
Upcoming IPOs
Substrate Artificial Inteligence, S.A.
View ApplicationIssue type
ORD
Segment
Access
Projected admission date
TBC
About
Substrate AI is an artificial intelligence company based in Spain that creates, buys and scales companies around AI in diverse sectors such as fintech, agritech, energy, human resources, and health. All of them sell products and services built on the bio-inspired reinforced learning technology developed and patented by Substrate AI.
Blackpoint Biotech plc
View ApplicationIssue type
ORD
Segment
Access
Projected admission date
TBC
About
Blackpoint Biotech PLC is a medical cannabinoids company established to fulfil gaps in the medical cannabis market by creating products that provide fast onset of action and accurate dosing.
Mydecine Innovations Group Inc
View ApplicationIssue type
ORD
Segment
Access
Projected admission date
2023-10-10
About
The Company is an emerging biotech and life sciences company dedicated to developing and commercialising innovative solutions for treating mental health problems and enhancing wellbeing. The Company’s medical and scientific advisory board is building out an R&D pipeline of nature-sourced psychedelic-assisted therapeutics, novel compounds, therapy protocols, and unique delivery systems.